TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05676684

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: A: Dapagliflozin 10 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: A: Dapagliflozin 10 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone + Dapagliflozin
Description: C: Dapagliflozin 10 mg once daily plus Spironolactone 25mg/every other day or 25mg/day (can be adjusted according to potassium and renal function)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone + Dapagliflozin
Description: C: Dapagliflozin 10 mg once daily plus Spironolactone 25mg/every other day or 25mg/day (can be adjusted according to potassium and renal function)
Study: NCT04781621

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Description: Participants will wear an exoskeleton suit and receive robotic gait training with a physical therapist for 90 minutes each week. Robot gait training will include standing and walking activities while wearing a robot suit. Participants will be asked to completed questionnaires about walking and function. They will also be asked to wear a watch measuring their heart rate monitor.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care Gait Training
Description: Participants receive usual care gait training with a physical therapist for 90 minutes each week. Usual care gait training may include standing and walking activities while using a treadmill or walker. Participants will be asked to completed questionnaires about walking and function. They will also be asked to wear a watch measuring their heart rate monitor and number of steps.
Study: NCT05080972

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: in-the-kNOW mobile app
Description: in-the-kNOW is a mobile app with restricted access through a single-use registration code.~The app will be developed with regular input from Black women enrolled in Atlanta Healthy Start Initiative (AHSI).~The app will have culturally- and contextually targeted HIV prevention and optimal sexual health messaging.~Each participant will have 4 months to engage with the app, with e-reminders in time intervals preferred by the participants (a minimum of 3 times per week) via push notifications. During the 4-month study period, participants will receive push notifications to encourage the use of all app domains: My Logger, My Test, My Resources, and My Circle.~Research staff will complete 2-month check-ins via phone call or video chat with participants.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control condition will be a one-time virtual women's health counseling session with a healthcare provider. Participants will get information on~1. Sexual Transmitted Infections (STI)/HIV prevention,~2. Family planning, and~3. General health promotion (e.g., exercise and diet).~The control condition provides access to HIV prevention materials that are publicly available but that do not offer the dynamic and individually customized features of the health communication/new media research approach proposed herein.~Control group participants will continue to receive the usual care associated with Atlanta Healthy Start Initiative (AHSI) enrollment.~The control group will not have access to intervention content (e.g. commodity ordering) until after the study has concluded.~Research staff will complete 2-month check-ins via phone call or video chat with participants.
Study: NCT06490796

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expanded diaphragm exercise
Description: Individuals will be instructed in 360-degree expansive diaphragm exercises using the Ohmbelt device (Nilus Medical LLC, OHMBELT, Redwood City, CA, USA). Two Ohmbelt devices will be used in this study. The placement of the devices will be as described in the literature (14,23,24): The patient will be in a seated position with hips and knees flexed at 90 degrees, both feet supported on the ground, and sitting upright on a chair without back support. In this position, the Ohmbelt devices will be secured to the patient's body. Following respiratory exercises, they will be individually enrolled in the evidence-based consensus program for three-dimensional functional exercises recommended for AS patients (26,27). The exercise protocol, which includes warm-up, mobility, stretching, flexibility, and cool-down periods, will last for 20 minutes

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard diaphragm exercise
Description: Individuals in this group will be instructed in standard diaphragm exercises. They will be asked to lie on their backs with their heads and knees supported by pillows, and to close their eyes to focus before starting. Following respiratory exercises, they will be individually enrolled in the evidence-based consensus program for three-dimensional functional exercises recommended for AS patients (26,27). The exercise protocol, which includes warm-up, mobility, stretching, flexibility, and cool-down periods, will last for 20 minutes.
Study: NCT05376358

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MoodRing App
Description: Adolescents and parents in the MR arm will receive instructions to download the MR app and AWARE app, customize the app, utilize an app-based self-guided onboarding, and review questions with the research team. The MR app provides the adolescent and their parent a notification to view a weekly report predicting their mood score (i.e. depression severity level similar to the Patient health questionnaire-9). The MR app will provide a library of coping strategies for adolescents and opportunities to self-track their mood.~Clinicians in the MR Arm will get access to a MR portal online. They will be able to view patients they are a provider for. The clinician will receive in-person and/or video-based training to use the portal.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Adolescents and parents in the usual care arm will receive instructions to download the AWARE app. This app will only track data and will not be interactive. Otherwise they will receive care as per routine by their healthcare provider team.
Study: NCT06210698

Intervention type: DIAGNOSTIC_TEST
Intervention: Venipuncture
Description: venipuncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Venipuncture
Description: venipuncture
Study: NCT05075525

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Laser Therapy Group
Description: High Intensity Laser Therapy (HILT) and exercises will be used.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound and Transcutaneous Electrical Nerve Stimulation Group
Description: Transcutaneous electrical nerve stimulation(TENS), ultrasound (US) will be applied.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound and Interferential Current Stimulation Group
Description: Ultrasound (US) ,interferential current stimulation and exercise will be used.
Study: NCT05337579

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Supplemental Micro Breaks
Description: Supplemental Micro Breaks, of 30 seconds after every 15 minutes of working on a static computer workstation in addition to the two 'Conventional Rest Breaks' of 15 minutes twice a day during the work hours

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supplemental Micro Breaks
Description: Supplemental Micro Breaks, of 30 seconds after every 15 minutes of working on a static computer workstation in addition to the two 'Conventional Rest Breaks' of 15 minutes twice a day during the work hours

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Breaks
Description: Exercise Breaks, of 10 minutes, twice a day during the work hours, in addition to the two 'Conventional Rest Breaks' of 15 minutes, twice a day during the work hours.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Breaks
Description: Exercise Breaks, of 10 minutes, twice a day during the work hours, in addition to the two 'Conventional Rest Breaks' of 15 minutes, twice a day during the work hours.
Study: NCT01582022

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: local application for 5 minutes

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: local application for 5 minutes
Study: NCT06108713

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Addition of juggling
Description: Participants will not change ther daily activities, and participate in juggling intervention lasted 4 weeks and consisted of 12 meetings (3 trainings per week), each lasting 45 minutes.
Study: NCT02520375

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prebiotic

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Study: NCT05140512

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY01005
Description: LY01005 was administered as 3 intramuscular (IM) injections, 28 days apart. As concomitant medications, Casodex® (50 mg/day) was orally administered during the whole study period.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ZOLADEX® 3.6 mg
Description: ZOLADEX® was administered as 3 Subcutaneous (SC) injections, 28 days apart. As concomitant medications, Casodex® (50 mg/day) was orally administered during the whole study period.
Study: NCT06240000

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Radiofrequency ablation
Description: Firstly, the posterior superior iliac spine was showed in the transverse plane, and it was gradually moved proximally until gluteus maximus muscle disappears and gluteus medius arises. Medial branch of the SCN is seen between iliac crest and thoracolumbar fascia as an ovoid structure. Radiofrequency device was utilized with 22-gauge 10-cm, 5 mm RF cannulas for all procedures. Cannula was placed thorough the SCN area and Sensory fiber stimulation was started between 0.3 and 0.5 V. The patient was asked for feedback on symptoms such as numbness, paresthesia or pain. If the patient did not report any sensory symptoms within the specified sensory stimulation range, the cannula was repositioned. Motor stimulation was given up to 1.5 V and it was checked whether there was any contraction or not. If there is no contraction detected, the SCN was ablated at 42° degrees centigrade for 240 seconds.
Study: NCT06462300

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A meaning-centered intervention for young women with weight and shape concerns
Description: * adapted version of the manualized meaning-centered psychotherapy for cancer patients developed by van der Spek et al. (2017)~* six weekly individual online sessions, each lasting one hour~* sessions led by a certified trainer~* four sources of meaning will be explored: personal life story, dealing with life's limitations, creating one's own life, and meaningful experiences~* homework assignments designed to deepen participants' experience and reflection on meaning in their daily lives
Study: NCT03761511

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotinamide
Description: Nicotinamide 4 g (capsules) or highest tolerated dose with a minimum of 2 g/d per os once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo (capsules) once daily
Study: NCT06075342

Intervention type: BEHAVIORAL
Intervention: exercise
Description: Exercise intervention according to the training program

Intervention type: BEHAVIORAL
Intervention: exercise
Description: Exercise intervention according to the training program

Intervention type: BEHAVIORAL
Intervention: exercise
Description: Exercise intervention according to the training program

Intervention type: BEHAVIORAL
Intervention: exercise
Description: Exercise intervention according to the training program
Study: NCT05418673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB122
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BIIB122-Matching Placebo
Description: Administered as specified in the treatment arm.
Study: NCT05488600

Intervention type: BEHAVIORAL
Intervention: Executive Function Assessment
Description: Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.

Intervention type: BEHAVIORAL
Intervention: Executive Function Assessment
Description: Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.

Intervention type: BEHAVIORAL
Intervention: Executive Function Assessment
Description: Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.
Study: NCT05947994

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intracranial stenting with Credo® stent
Description: Symptomatic ischemic stroke patients were treated with Credo® Stent
Study: NCT04492098

Intervention type: DIAGNOSTIC_TEST
Intervention: MAIT cells
Description: 1- Decidual tissues will be washed in phosphate buffer saline (PBS), and then preserved in Rosewell Park Memorial Institute (RPMI) 1640 medium supplemented with 100 U/mL penicillin, 100 mg/mL streptomycin and 5% fetal bovine serum (GIBCO BRL, Thermo Fisher Scientific, USA) until transfer to the laboratory. At the flow cytometry laboratory, the tissue samples will be minced finely and enzymatically digested by adding 3 ml collagenase enzyme type Ia and 2 ml PBS for 40 minutes at 37°C in shaking water path at 100 r.p.m. Cell suspensions obtained will be filtered, then the pellet after centrifugation will be treated with red blood cells lysing solution and washed with PBS.
Study: NCT06295367

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive PAF brochure describing financial navigation services

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive PAF brochure describing financial navigation services

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Financial Navigation
Description: Receive CostCOM financial counseling

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Participate in a 1 on 1 in-depth interview

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study: NCT05534906

Intervention type: OTHER
Intervention: Blood & Urine Samples
Description: Blood and urine samples will be collected to help identify biomarkers that can be used to detect liver cancer at the earliest possible time

Intervention type: OTHER
Intervention: Blood & Urine Samples
Description: Blood and urine samples will be collected to help identify biomarkers that can be used to detect liver cancer at the earliest possible time

Intervention type: OTHER
Intervention: Imaging
Description: MRI \& MRE Scans
Study: NCT05175573

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SuperNO2VA Et Nasal Positive Pressure Mask
Description: Nasal mask with capnography providing continuous positive airway pressure at 10LPM

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Supplemental Oxygen Face Mask
Description: Face mask with capnography providing oxygenation at 10 LPM
Study: NCT05242731

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MSmonitor, a self-management/education program with e-health interventions
Description: A self-management/education program with e-health interventions

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Video calling program Better-close
Description: Video calling program.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Researchmanager program
Description: Case Report Form, Datamanagement program

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Researchmanager program
Description: Case Report Form, Datamanagement program
Study: NCT06400173

Intervention type: BEHAVIORAL
Intervention: Cognitive screening
Description: The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.

Intervention type: BEHAVIORAL
Intervention: Cognitive screening
Description: The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.

Intervention type: BEHAVIORAL
Intervention: Cognitive screening
Description: The Dutch Montreal Cognitive Assessment for persons with hearing loss (MoCA-HI) is a modified version of the original MoCA test specifically designed for individuals with hearing loss. It includes adaptations such as visual aids to accommodate for hearing loss, ensuring fair assessment of cognitive abilities in this population.

Intervention type: BEHAVIORAL
Intervention: Audiological Assessment
Description: Four audiological tests are included in the audiological assessment~1. Tympanometry to assss the middle ear status~2. Pure-tone audiometry with headphone to evaluate the hearing thresholds~3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise~4. The hAVICOP questionnaire to assess the hearing-related quality of life

Intervention type: BEHAVIORAL
Intervention: Audiological Assessment
Description: Four audiological tests are included in the audiological assessment~1. Tympanometry to assss the middle ear status~2. Pure-tone audiometry with headphone to evaluate the hearing thresholds~3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise~4. The hAVICOP questionnaire to assess the hearing-related quality of life

Intervention type: BEHAVIORAL
Intervention: Audiological Assessment
Description: Four audiological tests are included in the audiological assessment~1. Tympanometry to assss the middle ear status~2. Pure-tone audiometry with headphone to evaluate the hearing thresholds~3. Speech audiometry in free field to assess the ability to understand spoken words in the presence of background noise~4. The hAVICOP questionnaire to assess the hearing-related quality of life
Study: NCT05774925

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: saliva obtaining
Description: The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: saliva obtaining
Description: The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: saliva obtaining
Description: The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.
Study: NCT05378997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TCP-25 gel 0.86 mg/ml or placebo gel
Description: TCP-25 gel (0.86 mg/mL) applied to two wounds per patient and placebo gel applied to two wounds per patient

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TCP-25 gel 2.9 mg/ml or placebo gel
Description: TCP-25 gel (2.9 mg/mL) applied to two wounds per patient and placebo gel applied to two wounds per patient

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TCP-25 gel 8.6 mg/ml or placebo gel
Description: TCP-25 gel (8.6 mg/mL) applied to two wounds per patient and placebo gel applied to two wounds per patient
Study: NCT05799079

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Given by mouth

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cedazuridine
Description: Given by mouth

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study: NCT06097715

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: upper gastrointestinal endoscopy
Description: Upper gastrointestinal endoscopy to asses present of esophageal varices and will be done to all patient group

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 1- Complete blood count 2- Coagulation profile
Description: cmplete blood count to detect thrombocytopenia, liver function test to detect if they are elevated,and any impaired coagulation profile

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 1- Complete blood count 2- Coagulation profile
Description: cmplete blood count to detect thrombocytopenia, liver function test to detect if they are elevated,and any impaired coagulation profile